Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region

Aim. To assess dynamics of glycated hemoglobin levels and insulin doses per kg bw in children and adolescents with poorly controlled type 1 diabetes mellitus using insulin pumps. Materials and methods. Retrospective analysis of HbA 1c levels and insulin doses per kg bw in children aged 2-17 years with DM1 (mean duration 5.3?3.1) before and 18 months after onset of insulin pump therapy (Medtronic Minimed 712 and 722) with a short-acting insulin analog Novopramid (Novo Nordisk) or Humalog (Ely Lilly) given to 55 (52,4%) and 50 (47,6%) of the patients respectively. НbА1с level and mean daily insulin dose per kg bw were determined when a patient visited the doctors office every 3 months. Results. Insulin pump therapy in patients with initially poorly controlled DM1 resulted in a decrease of HbA 1c from 9.8?0.8 to 7,8?0,5% within 18 months after its beginning (p Conclusion. Insulin pump therapy is an efficacious tool for the improvement of metabolic control in children and adolescents with poorly compensated CD1 regardless of age and duration of the disease.